Antibody-enhanced microdialysis collection of CCL2 from rat brain

Journal of Neuroscience Methods

Volumn 202, Issue 2, 2011, Pages 124-127

  Herbaugh, Anthony W ^a   Stenken, Julie A ^a  

^a UNIVERSITY OF ARKANSAS   (United States)

Author keywords

Antibody; Brain; CCL2 MCP 1; Enhanced relative recovery; Microdialysis sampling; Rat

Indexed keywords

MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ARTICLE; CALIBRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW RATE; IN VITRO STUDY; IN VIVO STUDY; MICRODIALYSIS; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RAT;

AFFINITY LABELS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; BRAIN; CHEMOKINE CCL2; MALE; MICRODIALYSIS; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY;

EID: 81055157123     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2011.05.006     Document Type: Article

References (34)

1. Adler M.W., Geller E.B., Chen X., Rogers T.J. Viewing chemokines as a third major system of communication in the brain. AAPS J 2005, 7:E865-E870.
2. Adler M.W., Rogers T.J. Are chemokines the third major system in the brain?. J Leukoc Biol 2005, 78:1204-1209.
3. Ambrosini E., Aloisi F. Chemokines and glial cells: a complex network in the central nervous system. Neurochem Res 2004, 29:1017-1038.
4. Ao X., Stenken J.A. Microdialysis sampling of cytokines. Methods 2006, 38:331-341.
5. Bajetto A., Bonavia R., Barbero S., Florio T., Schettini G. Chemokines and their receptors in the central nervous system. Front Neuroendocrinol 2001, 22:147-184.
6. Chui R., Dorovini-Zis K. Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide. J Neuroinflammation 2010, 7.
7. Conductier G., Blondeau N., Guyon A., Nahon J.-L., Rovere C. The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J Neuroimmunol 2010, 224:93-100.
8. Daly C., Rollins B.J. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation 2003, 10:247-257.
9. Deshmane S.L., Kremlev S., Amini S., Sawaya B.E. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009, 29:313-326.
10. Dhillon N.K., Williams R., Callen S., Zien C., Narayan O., Buch S. Roles of MCP-1 in development of HIV-dementia. Front Biosci 2008, 3913-3918.
11. Duo J., Fletcher H., Stenken J.A. Natural and synthetic affinity agents as microdialysis sampling mass transport enhancers: current progress and future perspectives. Biosens Bioelectron 2006, 22:449-457.
12. Fletcher H.J., Stenken J.A. An in vitro comparison of microdialysis relative recovery of Met- and Leu-enkephalin using cyclodextrins and antibodies as affinity agents. Anal Chim Acta 2008, 620:170-175.
13. Greenbaum D., Jansen R., Gerstein M. Analysis of mRNA expression and protein abundance data: an approach for the comparison of the enrichment of features in the cellular population of proteins and transcripts. Bioinformatics 2002, 18:585-596.
14. Hayashi M., Luo Y., Laning J., Strieter R.M., Dorf M.E. Production and function of monocyte chemoattractant protein-1 and other β-chemokines in murine glial cells. J Neuroimmunol 1995, 60:143-150.
15. He J., Crews F.T. Increased MCP-1 and microglia in various regions of the human alcoholic brain. Exp Neurol 2008, 210:349-358.
16. Helmy A., Carpenter Keri L.H., Skepper Jeremy N., Kirkpatrick Peter J., Pickard John D., Hutchinson Peter J. Microdialysis of cytokines: methodological considerations, scanning electron microscopy, and determination of relative recovery. J Neurotrauma 2009, 26:549-561.
17. Helmy A., Carpenter K.L.H., Menon D.K., Pickard J.D., Hutchinson P.J.A. The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production. J Cereb Blood Flow Metab 2011, 31:658-670.
18. Kuriyama N., Mizuno T., Kita M., Nagakane Y., Hosomi A., Harada S., et al. Predictive markers of blood cytokine and chemokine in recurrent brain infarction. J Interferon Cytokine Res 2009, 29:729-734.
19. Magge S.N., Malik S.Z., Royo N.C., Chen H.I., Yu L., Snyder E.Y., et al. Role of monocyte chemoattractant protein-1 (MCP-1/CCL2) in migration of neural progenitor cells toward glial tumors. J Neurosci Res 2009, 87:1547-1555.
20. Maier T., Gueell M., Serrano L. Correlation of mRNA and protein in complex biological samples. FEBS Lett 2009, 583:3966-3973.
21. Maurer M.H., Haux D., Unterberg A.W., Sakowitz O.W. Proteomics of human cerebral microdialysate: from detection of biomarkers to clinical application. Proteomics Clin Appl 2008, 2:437-443.
22. McNay E.C., Sherwin R.S. From artificial cerebro-spinal fluid (aCSF) to artificial extracellular fluid (aECF): microdialysis perfusate composition effects on in vivo brain ECF glucose measurements. J Neurosci Methods 2004, 132:35-43.
23. Mellergard P., Aneman O., Sjogren F., Pettersson P., Hillman J. Changes in extracellular concentrations of some cytokines, chemokines, and neurotrophic factors after insertion of intracerebral microdialysis catheters in neurosurgical patients. Neurosurgery 2008, 62:151-157. [discussion 7-8].
24. Pich E.M., Koob G.F., Heilig M., Menzaghi F., Vale W., Weiss F. Corticotropin-releasing factor release from the mediobasal hypothalamus of the rat as measured by microdialysis. Neuroscience 1993, 55:695-707.
25. Quan N., Herkenham M. Connecting cytokines and brain: a review of current issues. Histol Histopathol 2002, 17:273-288.
26. Cytokines and the CNS 2006, CRC Press, Taylor & Francis, Boca Raton, FL. 2nd ed. R.M. Ransohoff, E.N. Benveniste (Eds.).
27. Schilling M., Strecker J.K., Schabitz W.R., Ringelstien E.B., Kiefer R. Effects of monocyte chemoattractant 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice. Neuroscience 2009, 161:806-812.
28. Shen Y.-Q., Hebert G., Lin L.-Y., Luo Y.-L., Moze E., Li K.-S., et al. Interleukin-1beta and interleukin-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization. J Neuroimmunol 2005, 158:14-25.
29. Signore A., Mather S.J., Piaggio G., Malviya G., Dierckx R.A. Molecular imaging of inflammation/infection: nuclear medicine and optical imaging agents and methods. Chem Rev 2010, 110:3112-3145.
30. Ståhle L. Pharmacokinetic estimations from microdialysis data. Eur J Clin Pharmacol 1992, 43:289-294.
31. Thompson W., Karpus W., Van Eldik L. MCP-1-deficient mice show reduced neuroinflammatory responses and increased peripheral inflammatory responses to peripheral endotoxin insult. J Neuroinflammation 2008, 5:35.
32. Wang X., Lennartz M.R., Loegering D.J., Stenken J.A. Interleukin-6 collection through long-term implanted microdialysis sampling probes in rat subcutaneous space. Anal Chem 2007, 79:1816-1824.
33. Watkins L.R., Maier S.F. Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med 2005, 257:139-155.
34. Woodroofe M.N., Sarna G.S., Wadhwa M., Hayes G.M., Loughlin A.J., Tinker A., et al. Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J Neuroimmunol 1991, 33:227-236.